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Notch signaling plays an instrumental role in hippocampus-dependent memory formation
and recent evidence indicates a displacement of Notch1 and a reduction its activity in
hippocampal and cortical neurons from Alzheimer’s disease (AD) patients. As Notch
activation depends on ligand availability, we investigated whether Jagged1 expression
was altered in brain specimen of AD patients. We found that Jagged1 expression was
reduced in the CA fields and that there was a gradual reduction of Jagged1 in the
cerebrospinal fluid (CSF) with the progression of dementia. Given the role of Notch
signaling in memory encoding, we investigated whether targeted loss of Jagged1 in
neurons may be responsible for the memory loss seen in AD patients. Using a transgenic
mouse model, we show that the targeted loss of Jagged1 expression during adulthood is
sufficient to cause spatial memory loss and a reduction in exploration-dependent Notch
activation. We also show that Jagged1 is selectively enriched at the presynaptic terminals
in mice. Overall, the present data emphasizes the role of the Notch ligand, Jagged1, in
memory formation and the potential deficit of the signaling ligand in AD patients.
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INTRODUCTION
The Notch pathway is one of the most conserved signaling cascades regulating cellular
communication, cell fate specification and morphogenesis from development onward (Artavanis-
Tsakonas et al., 1999; Huppert et al., 2000; Pierfelice et al., 2011; Guruharsha et al., 2012). In the
past two decades, a wealth of studies have demonstrated that Notch signaling is fundamental
for neurophysiological processes such as learning and memory in a variety of species, including
mammals (Alberi et al., 2013). Our group has previously shown that the loss of Notch1 from the
CA1 subfield of the hippocampus of mice results in a significant impairment in LTP and LTD and
a considerable deficit in hippocampus-dependent spatial memory. Furthermore, at a mechanistic
level, we have shown that in the absence of Notch1, NMDA currents are significantly reduced
and downstream activation of cAMP response element binding (CREB) protein is profoundly
affected (Brai et al., 2015), likely accounting for the plasticity deficit. The Notch1-CREB axis has
been prevously reported in fruit flies, where Notch1 protein has been shown to be essential for
CREB hyperphosphorylation and its subsequent activation (Zhang et al., 2013). These works clearly
establish Notch signaling as an important modulator in the process of memory encoding (Marathe
and Alberi, 2015).
Given that the memory loss is a prominent behavioral symptom of AD, we recently showed that
Notch signaling is compromised in the brains of AD patients (Brai et al., 2016), inferring a causal
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relationship between alterations in Notch1 function and memory
impairment, which we further explore in this manuscript.
Notch receptors are activated through ligand binding, which
triggers a sequential cleavage by metalloproteases and the γ -
secretase complex (Kopan and Ilagan, 2009). TheNotch receptors
are activated by the Jagged and Delta Serrate family of ligands
containing a conserved DSL (Delta/Serrate/Lag-2) domain that
is necessary for binding with the receptor (D’Souza et al., 2008).
Canonical and non-canonical ligands, like Jagged1 and DNER,
have been extensively characterized in the context of Notch
signaling and appear to be exclusively involved in activation of
this pathway (Alberi et al., 2013). However, since Notch is highly
interlinked with other signaling cascades, e.g., Wnt (Hayward
et al., 2005) and Reelin (Hashimoto-Torii et al., 2008), Notch
ligands may have additional roles on cell functions by indirectly
influencing other cellular pathways. Our previous study showed
that Jagged1 is highly expressed in cultured neurons, whereas
the expression of Delta like-1 is negligible. Moreover, Jagged1
colocalizes with presynaptic markers and its expression is
increased upon synaptic activation (Alberi et al., 2011). The
involvement of Jagged1 in mediating Notch-dependent plasticity
was suggested by another study usingmice carrying a constitutive
heterozygous null allele of Jagged1 (Jagged1+/− mice), which
displayed a significant deficit in hippocampus-dependent spatial
memory (Sargin et al., 2013) resembling Notch1 depletion
(Costa et al., 2003; Alberi et al., 2011). Although, a potential
neurodevelopmental deficit in the Jagged1+/− mice can not be
excluded as contributing factor to the behavioral deficit, the
existing data suggest that Jagged1 might be the most relevant
Notch ligand to be investigated in the context of memory
impairment and AD pathophysiology. In this paper, we show
that Jagged1 expression is significantly and progressively affected
in AD, we demonstrate that conditional loss of Jagged1 in
hippocampal neurons affects memory formation and activity-
dependent Notch signaling. Lastly, we confirm that Jagged1
is enriched presynaptically in hippocampal neurons from the
mouse brain. We believe that investigation of Notch ligands
involved in memory formation is critical in order to better
understand the role of Notch signaling in AD and ultimately
devise more effective therapeutic strategies against dementia.
MATERIAL AND METHODS
Human Tissue
The human samples were generously provided from the Brain
Bank for Dementia Research, Oxford, UK. We received paraffin
embedded brain sections from the entorhinal cortex of 5 controls
and 5 sporadic AD patients and frozen CSF from a second
group of 6 non-demented controls and 6 AD patients (Table 1).
CSF from living patients was obtained through the Memory
Clinic of the Cantonal Hospital of Fribourg (Table 1). The use
of human postmortem tissue has been approved by the Ethical
commission of the Brain Bank for Dementia UK [OBB ID N.
TW344, OBB ID N. TW296 and the Swiss Ethical Commission
(CER-VD N. 2014-325)]. The use of ex-vivo human specimen for
basic research purposes is licensed by Swiss Ethical Commission
TABLE 1 | Human specimen.
Patient
ID
Age Sex Braak
staging
(Braak and
Braak, 1991)
CERAD Tissue Applications
035/13 85 m 5 Definite AD EC/HP IHC
016/12 64 f 6 Definite AD EC/HP IHC
089/11 83 f 6 Definite AD EC/HP IHC
133/12 78 m 6 Definite AD EC/HP IHC
100/12 90 m 4 Probable AD EC/HP IHC
1117/00 91 f 6 Definite AD CSF WB
C4295 84 m 6 Definite AD CSF WB
142/05 87 m 6 Definite AD CSF WB
C4298 76 m 5-6 Definite AD CSF WB
C4130 79 f 5-6 Definite AD CSF WB
036/02 69 f 6 Definite AD CSF WB
169/11 84 f 2 Normal EC/HP IHC
071/13 83 f 2 Normal EC/HP IHC
136/12 77 f 1 Normal EC/HP IHC
121/12 89 f 2 Normal EC/HP IHC
048/12 65 f 1 Normal EC/HP IHC
048/02 89 m 1 Normal CSF WB
1085/03 67 m 1 Normal CSF WB
053/06 71 m 1 Normal CSF WB
083/01 79 f 0 Normal CSF WB
1050/00 81 f 1 Normal CSF WB
1182/94 80 f 1 Normal CSF WB
Patient ID Age Sex MMSE CDR Tissue Applications
145/14 73 m 26/30 0 CSF WB
530/14 74 f 29/30 0 CSF WB
907/14 79 f 20/30 0 CSF WB
569/15 65 m 30/30 0 CSF WB
860/15 65 m 28/30 0 CSF WB
462/15 64 m 15/30 1.5 CSF WB
204/14 76 f 22/30 1 CSF WB
845/15 79 f 22/30 1 CSF WB
777/15 80 m 21/30 1.5 CSF WB
155/15 84 m 19/30 1.5 CSF WB
CERAD, Consortium to Establish a Registry for Alzheimer’s Disease; HP, Hippocampus;
EC, Entorhinal Cortex; MMSE, Minimal Mental State Evaluation; CDR, Clinical Dementia
Rating.
(CER-VD N.2016-01627). All experiments conducted on human
tissue comply with the WMA Declaration of Helsinki.
Mice
Mouse behavior experiments were performed with permission
of the local animal care committee (Canton of Fribourg,
Switzerland) and according to the present Swiss law and the
European Communities Council Directive of November 24 1986
(86/609/EEC). Mice were housed with littermates in standard
IVC mouse cages in a temperature and humidity controlled
animal room. All mice weremaintained on a 12-h light/dark cycle
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and all testing was performed during the light phase. Food and
water were available ad libitum.
Jagged1flox/flox mice (Nyfeler et al., 2005) (gift from Dr.
Verdon Taylor, UNIBAS) were crossed with the B6;129S6-
Tg(Camk2a-cre/ERT2)1Aibs/J (Madisen et al., 2010) (Jackson
Laboratory) to generate excitatory neuron specific, tamoxifen-
inducible Jagged1 conditional knockout (Jagged1cKO) mice.
Two months old Jagged1cKO mice were injected i.p. with 67
mg/kg of tamoxifen (TAM) every day for 10 consecutive days.
The mice were then left for at least 10 additional days for the
existing Jagged1 protein to dissipate.
No Jagged1cKO mouse was treated with TAM prior to 2
months of age to avoid developmental abnormality. Control
(CTL) mice were either TAM-injected Tg(Camk2a-cre/ERT2) or
uninjected Jagged1cKO.
Immunolabeling
Reagents for immunolabeling
Following primary antibodies were used for fluorescent
immunohistochemistry on slices: goat anti Notch1 (Santa
Cruz Biotechnology, cat. no. SC6014), goat anti Jagged1
(Santa Cruz Biotechnology, cat. no. SC6011), rabbit anti NeuN
(Abcam, cat. no. ab177487), mouse anti Hes5 (Abcam, cat. no.
ab25374). Misfolded β-sheets were stained with Thioflavin-
T (Abcam, cat.n. ab120751) at a concentration of 100 mM
diluted in water, following the manufacturer’s instructions.
Nuclei were counterstained with DAPI (Thermo Fisher
Scientific). The primary antibodies used for the chromogen
immunohistochemistry on mouse brain sections were rabbit
anti Jagged1 (Abcam, cat. no.ab7771) and goat anti-Notch1(sc-
6014; Santa Cruz Biotechnology, USA). The rabbit anti
Jagged1 (Abcam, cat. no.ab7771) was used for immuno-
electronmicroscopy (ImmunoEM). Antibodies used for
Western blot analysis were: rabbit anti Jagged1 (Abcam, cat.
no. ab7771), mouse anti Jagged1 (Novus Biologicals, cat.
no. H00000182-M01A), rabbit anti DNER (Abcam, cat. no.
ab174484), and mouse anti GAPDH (Santa Cruz Biotechnology
cat. no. SC365062). The secondary antibodies used for the
immunofluorescence were Cy2, Cy3, or Cy5 conjugated
donkey anti-goat, Cy2 and Cy3 conjugated donkey anti-rabbit,
Cy3 donkey anti-mouse. The secondary antibodies for the
chromagen immunohistochemistry were biotinylated donkey
anti rabbit and biotinylated donkey anti rabbit. All fluorescent
or biotynilated conjugated antibodies were purchased from
Jackson Immunoresearch Europe Ltd and were diluted 1:500 for
fluorescent immunohistochemistry and 1:2,000 for fluorescent
immunoblots.
Immunohistochemistry
Paraffin sections from humans and floating mouse sections
were processed either for fluorescent or chromagen immuno-
histochemistry according to the previously published protocols
(Brai et al., 2015; Marathe et al., 2015). For fluorescent
immunolabelings, DAPI was used for nuclear counter-
staining. Fluorescent immunolabeled section where imaged
at the confocal microscope (Zeiss LSM 700). Chromagen
immmunolabeled sections were imaged using an optical slide
scanner (Nanozoomer Hamamatsu 2.0 HT). The fluorescence
intensity (integrated pixel density) of the immunolabeled
proteins on human and mouse brain sections were measured
on Region of Interest (ROI) drawn on the perimeter of the cell
bodies, using the ROI manager and particle analysis tool of
ImageJ (https://imagej.nih.gov/ij/).
Immuno Electron Microscopy and Quantitation
The mice were transcardially perfused with 4% PFA and
0.1% glutaraldehyde. The Immunoelectromicroscopy (IEM)
was carried out on hippocampal sections from 3 WT mice
using the Rabbit anti Jagged1 primary antibody (Abcam, cat.
no.ab7771) according to the published protocol (Brai et al.,
2016). For particles quantification, the size of each 8-bit image
was calibrated according to the magnification indicated by the
scale bar. The particle were separated from the background
by adjusting the threshold for pixel identification within the
grayscale range of 0–70. For delimiting the pixel counts on
presynaptic and postsynaptic areas, ROIs were drawn manually
following the visible presynaptic and postsynaptic membranes
and closed at the top or bottom to form confined areas,
which were measured using the Measure function of ImageJ
(presynaptic area: 82.3 ∗ 103 ± 66.1 ∗ 103 nm2, postsynaptic
area: 57.3 ∗ 103 ± 32.8 * 103 nm2; t40 = 0.89, p = 0.38, n =
21 presynaptic and n = 21 postsynaptic areas). Particles were
counted automatically by setting the size within the range: 1.40-
Infinity and circularity within the range: 0.10–1.00. The number
of resulting particles was divided by the value of the presynaptic
or postsynaptic area in nm2.
Immunoblotting
Western blot on tissue lysates and CSF was performed as
previously described (Marathe et al., 2015; Brai et al., 2016).
Visualization was performed through a fluorescent imager
(Omega Lum G from Aplegen). The optical density of each band
was assessed through ImageJ, using the gel tool application and
bands were normalized to GAPDH.
Behavioral Tests
Jagged1cKO and CTL mice were used in all behavioral
tests. To control for the potential off-target effect of TAM
on cognitive performance, the majority of CTL mice were
TAM-injected Tg(Camk2a-cre/ERT2). To assess whether TAM
may influence behavior, Anxiety behavior was examined
between CTL groups, TAM-injected Tg(Camk2a-cre/ERT2) and
uninjected Jagged1cKOs, using the open field test [TAM-
injected Tg(Camk2a-cre/ERT2): 309.65 ± 6.15 s, non injected
Jagged1cKO : 325.10 ± 29.20 s; F(1, 7) = 0 .23, p = 0.62, n = 4
animals per genotype]. Differences in hippocampus-dependent
memory were tested using Novel Object Displacement (NOD)
test [TAM-injected Tg(Camk2a-cre/ERT2): 87.87 ± 7.98%, non
injected Jagged1cKO : 81.67 ± 15.66%; F(1, 10) = 0.22, p = 0.8,
n= 6 animals per genotype].
Mice were habituated to the behavior room for at least three
days before the beginning of the behavioral tests and were
handled daily by the experimenter during this period.
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To test the unprovoked locomotor behavior and baseline
anxiety levels, mice were introduced in an open arena (60 X
60 cm square box) and were allowed to explore freely for 10
min. The video was recorded using a webcam mounted on top
of the arena and the movement of mice was tracked using an
ImageJ plugin OFT (https://cbsn.neuroinf.jp/modules/xoonips/
detail.php?id=ImageOF). The average speed was calculated
during the period when mice were actively moving, while the
periods where they were immobile were discarded. Also, time
spent and the distance traveled in the central quadrant was
quantified.
The conditional knockout mice and the CTL mice were also
tested on an elevated plus maze, in which mice were allowed
to explore a plus-shaped maze with two open and two closed
arms. The maze was elevated 3 feet from the ground, so that the
open (un-walled) elevated arms create an anxiogenic atmosphere.
The video was recorded using a webcam mounted on top of
the arena and the movement of mice was tracked using an
ImageJ plugin EPM (https://cbsn.neuroinf.jp/modules/xoonips/
detail.php?id=ImageEP). Time spent in the open arms as a
percentage of total time was quantified to assess anxiety behavior.
Mice were tested for hippocampus-dependent memory
behavior on the Y-maze (hidden arm version) test and the NOD
test. Y-maze was performed as described previously (Alberi et
al., 2011) in a Y-shaped maze with three walled arms (height:
12.7 length: 38.3, width: 7.6 cm) at 1200 angle from one another.
The animals were placed at the center of the maze, facing the
wall and were left to explore the Y maze for 5 min. Spontaneous
alternation percentage was scored. The next day, one arm was
blocked (hidden arm, C) and the animals were allowed to
explore the remaining arms for 5 min. Twenty minutes after
the 2-arm exploration, all arms were left open and mice were
reintroduced in the Y maze for another 5 min. The mice were
videotaped and scored for number of entries and time spent in
each arm using stopwatch+ software (http://www.cbn-atl.org/
research/stopwatch.shtml).
The NOD test was performed in a rectangular arena,
to which the mice were first habituated for 3 consecutive
days for 15 min each. On 4th day, four objects of same
material but of distinctly different shapes and texture were
placed at four corners of the arena and the animals were
allowed to explore the arena with the four objects for 5
min. On 5th day, the animals again encountered the same
four objects for 5 min, except that two of them had
swapped positions. The behavior was recorded using a video
camera mounted on top of the arena and the behavior
was analyzed post-hoc from the videos. The object-location
discrimination index was calculated as (Time spent with
displaced objects / Total Time spent exploring all objects)∗100.
The object-location discrimination index of 50% indicated lack
of discrimination.
For studying protein expression changes following novel
environmental exploration, mice were taken from their home
cage and introduced into a rectangular arena containing 2 objects
of distinct color and texture. Mice were allowed to explore the
arena for 10 min after which they were returned to their home
cage. Forty-fiveminutes after exploration, mice were sacrificed by
transcardial perfusion with 4% PFA to study protein expression
by immunohistochemistry as shown previously (Alberi et al.,
2011; Brai et al., 2015).
Statistical Analysis
Statistical comparison of Jagged1 expression in hippocampal
neurons of post-mortem sections from healthy controls and
AD patients was obtained using one-way Anova with post-
hoc Bonferroni correction. Optical density analysis of bands on
Western Blot from human and mouse samples were analyzed
by using paired Student’s t-test to assess a significant difference
between two groups. The fluorescence intensity of Notch1 and
Hes5 was analyzed from randomly picked hippocampal neurons
and results between genotype compared by non-parametric
Mann Whitney Test. Behavioral differences between KOs and
CTL mice were quantified using one-way Anova with post-hoc
Bonferroni correction. For IEM analysis, comparison between
Jagged1 immunogold particles on the area of the the pre- and
post-synaptic terminal was carried out using one-way Anova
with post-hoc Bonferroni correction. All statistical analysis were
conducted using the Real Statistics add-in in Excel from Charles
Zaiontz (http://www.real-statistics.com/). The differences were
considered to be significant when the p-value was less than 0.05.
RESULTS
Jagged Expression in Hippocampi from AD
Patients
We have previously shown that Notch1 is significantly altered
in the hippocampus and entorhinal cortex of AD patients,
with reduced expression in pyramidal neurons as well as
decreased Notch1 activity (Brai et al., 2016). Based on the
well-established role of Notch1 in memory formation across
species, we investigated whether the cognate ligand Jagged1,
which is expressed in neurons and can be induced by synaptic
activity (Alberi et al., 2011), was also altered in post-mortem
specimens from patients with severe dementia (Table 1) and ex-
vivo CSF samples from patients with mild cognitive impairment
(MCI) based on the minimal mental score evaluation (MMSE;
Table 1). Our immunohistochemical analysis on post-mortem
sections comprising the hippocampus and entorhinal cortex
(Figure S1A), reveals that in AD patients the expression of
Jagged1 is substantially altered as compared to age-matched
healthy controls (Healthy CTLs; Figures 1A–C′). Moreover,
Jagged1 expression is evident in pixels in the parenchyma
in and around Thioflavin-T and Notch1 positive aggregates
(Figure 1B) and degenerated neurons, as indicated by the
condensed nuclei (white arrows, Figures 1B,B′). Jagged1 is
present in scattered depositions, around rosette-like plaques,
Thioflavin-T and Notch1 positive (Figures 1C,C′; magnified
insert). Analysis of Jagged1 immunofluorescence intensity in CA
field neurons, defined by the larger appearance of their neurons
and their sterotypical orientation, reveals a significant reduction
of Jagged1 [Healthy CTLs: 3293.62 ± 196.31, AD: 1969.28 ±
172.50; F(1, 279) = 25.69, p < 0.001; n = 122 neurons analyzed
in CTL and n = 158 neurons in AD sections, n = 5 patients
per condition; Figure 1D]. The expression of Jagged1 inversely
correlates with the staging of AD (r= −0.37; p< 0.001, Pearson’s
coefficient). Furthermore, analysis of the CSF indicates that
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FIGURE 1 | Jagged1 expression in brains and CSF of AD patients. Representative double fluorescent immunolabelings for Jagged1 (green) and Notch1 (red)
counterstained with Thioflavin-T or DAPI (blue) on postmortem brain sections comprising the hippocampal CA fields from healthy age-matched controls and AD
patients (A–C). In the healthy controls, Jagged1 is localized to the somata of neurons where also Notch1 is expressed. As expected, Thioflavin-T labeling is negligible
(A,A′). AD sections show fibrillary aggregates (B,B′) and (C,C′) core plaques double positive for Notch1 and Thioflavin-T. Jag1 expression is scattered in the
parenchyma and low in, degenerated neurons (white arrows) (B,B′). Jag1 overlays in small double positive aggregates for Notch1 and Thioflavin-T (100x
magnification) in radiating plaques with a visible reduction in Jagged1 cellular expression (B–C′). Box plots summarizing the quantification of the fluorescence
intensities of Jagged1 immunolabeled neurons shows a significant reduction in Jagged1 expression in AD patients (p < 0.001) (D). Immunoblotting on CSF from 6
patients per condition reveals that Jagged1 bands over 130 KDa corresponding to the full length (blue star) and the one below 130 KDa (red star) indicating the soluble
Jagged1 appear less represented in the CSF from AD patients (E). Bar graph showing the pattern of expression of Jagged1 bands >130 KDa (blue stars) and <130
KDa (red stars) (F). Representative immunoblotting of the CSF from the same patients with DNER shows the expected band <100 KDa (blue stars) and a stronger
undefinded band <27 KDa. Intenstity of the bands at both molecular weights show a high variability independently of the condition (G). Bar graph summarizes the
expression of the expected DNER band <100 KDa in CTLs and ADs (H). Bar graphs representing the quantification of the Jag1 bands >130 and <130 KDa and the
DNER band <100 KDa in MCI patients and age-matched CTLs (I,J). Scale bars are 25 µm in (A,A′). All graphs represent mean ± SEM, *p < 0.05. AU, arbitrary units.
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Jagged1 is present in different truncations and the bands above
130 KDa corresponding to the full length protein [HCTLs: 1 ±
0.25, AD: 0.24 ± 0.05; t(10) = 2.93, p = 0.01; n = 6 patients per
condition] and that below 130 KDa corresponding to the soluble
protein [HCTLs: 1± 0.27, AD: 0.21± 0.03; t(10) = 2.94, p= 0.02;
n = 6 patients per condition] appear to be substantially reduced
in 5 out of 6 AD patients examined as compared with healthy
CTLs (Figures 1E,F). Analysis of the expression of DNER, a
brain-specific Notch ligand (Eiraku et al., 2002; Kurisu et al.,
2010), in CSF reveals no difference between conditions [HCTLs:
1 ± 0.37, AD: 0.78 ± 0.30; t(10) = 0.98, p = 0.39; n = 6
patients per condition; Figures 1G,H]. Further analysis of CSF
obtained by spinal tap from patients with MCI (MMSE: 21 ±
1.77) and healthy age-matched controls (MMSE:25.4 ± 2.23)
reveals a tendency of Jagged1 to decrease in MCI [bands above
130 KDa; HCTLs: 1 ± 0.55, MCI: 0.22 ± 0.06; t(8) = 1.66, p =
0.13; bands below 130 KDa; HCTLs: 1 ± 0.33, MCI: 0.40 ± 0.11;
t(8) = 1.76, p= 0.11; n= 5 patients per condition; Figure 1I and
Figure S1B]. On the other hand, DNER’s levels are constant in
bothMCI andHealthy CTLs [HCTLs: 1± 0.16,MCI: 0.85± 0.19;
t(8) = 0.64, p= 0.54; n= 5 patients per condition; Figure 1J and
Figure S1C]. The progressive alteration of Jagged1 in the brain
specimens and the CSF of AD patients suggests a specific and
progressive imbalance in Jag1 availability in the CNS, which may
be clinically relevant.
Loss of Jagged1 Affects Spatial Memory
The reduction of Jagged1 in the brains of AD patients with
severe dementia primed us to understand whether the loss of
Jagged1 in neurons during adulthood is sufficient to induce
memory loss and could be functionally correlated to memory
decline in AD. We generated a Jagged1 conditional knockout
mouse line (Jag1cKO) by crossing Jagged1flox/flox (Nyfeler et
al., 2005) with B6;129S6-Tg1Aibs/J (Camk2a-cre/ERT2) mice
(Madisen et al., 2010). This strategy allowed us to obtain a
neuron-specific deletion of Exon 1 and Exon 2 of Jagged1
gene in adult mice only after Tamoxifen (TAM) treatment
(Figure 2A). This prevented any interference with prenatal
or early-postnatal neurodevelopment. TAM application was
performed in mice at 2–3 months of age and the loss of
Jagged1 protein expression from hippocampal neurons was
confirmed 10 days after TAM treatment. Using fluorescent
immunohistochemistry for Jagged1 and NeuN, we observed
a dramatic reduction in Jagged1 in hippocampal neurons as
compared to Camk2α-cre/ERT2 injected with TAM (indicated as
CTL; Figure 2B). Chromagen immunohistochemistry conferms
the deletion in the CA fields of Jagged1 in TAM-injected Jag1cKO
as compared to TAM-injected Camk2α-cre/ERT2 and uninjected
Jag1cKO (Figure S2A). Western Blot analysis on whole brain
tissue confirms a significant reduction (80%) of Jagged1 in the
Jagged1cKOmice [CTLs: 1± 0.05, Jagged1cKO: 0.17± 0.07; t(10)
= 12.69, p < 0.001, n = 6 animals per group], whereas DNER
appears unchanged [CTLs: 1 ± 0.21, Jagged1cKO: 1.01 ± 0.11;
t(10) = 0.21, p = 0.83, n = 6 animals per group; Figures 2C,D].
The robust loss in Jagged1 observable in the whole hippocampal
tissue, is a strong indication that Jagged1 expression is mostly
neuronal, as previously shown (Stump et al., 2002).
In order to correlate the loss of Jagged1 to memory decline, we
tested memory performance in the Jagged1cKO and compared
their performance to CTLmice. To exclude any interference from
a possible anxiety phenotype or motor deficits on the memory
task, we performed open-field and elevated plus maze tests. In
the open-field, locomotion quantified by walking speed [CTLs:
34.55 ± 0.98 cm/s, Jagged1cKO: 37.23 ± 1.6 cm/s; F(1, 8) =
2.29, p = 0.19, n = 4–5 animals per group] and anxiety behavior
measured by the time spent in the center [CTLs: 317.37 ± 14.17
s, Jagged1cKO: 350.89 ± 21.57 s; F(1, 8) = 0.99, p = 0.24, n =
4–5 animals per group]. To confirm the absence of an anxiety
phenotype in the Jagged1cKO, we used the elevated plus-maze
test and measured the time spent in the open arms [CTLs:
27.71 ± 5.09%, Jagged1cKO: 23.89 ± 9.45%; F(1, 8) = 0.59, p =
0.47, n = 4–5 animals per group]. Both Jagged1cKOs and CTLs
behave comparably as tested in the open field and elevated plus
maze. We then investigated hippocampus-dependent memory
by performing one-trial behavioral test for working memory (Y-
maze alternation) (Figure 2E), and spatial reference memory (Y-
maze hidden arm (Figure 2G) and Novel Object Displacement
(Figure 2I). We used the Y-maze spontaneous alternation test
that has been shown to be hippocampus-dependent (Sarnyai
et al., 2000) (Figure 2E). The alternation in Jagged1cKO group
(49.78 ± 2.55%) was close to chance (50%) in contrast to CTL
mice [67.98 ± 3.75%; F(1,8) = 13.68, p = 0.01, n = 4–5 animals
per group] (Figures 2E,F). The Y-maze hidden arm test (Alberi
et al., 2011) showed a significant reference memory deficit in the
Jagged1cKO mice as compared to CTL mice [ CTLs: 78.93 ±
4.16%, Jagged1cKO: 43.26 ± 14.2%; F(1, 9) = 8.29, p = 0.02, n =
5 animals per group; Figures 2G,H]. We next used the NOD test
(Mumby et al., 2002) to further validate thememory performance
in the Jagged1cKO mice. We found that the lack of Jagged1
worsens the memory performance in the NOD test [CTLs: 81.67
± 8.37%, Jagged1cKO: 48.5 ± 13.23%;F(1, 11) = 12.72, p <
0.001, n = 6 animals per group; Figures 2I,J]. The behavioral
tests demonstrate that Jagged1 expression in neurons is critical
for spatial memory and suggest that reduction in Jagged1
expression may contribute to the memory deficit observed in AD
patients.
Jagged1 Regulates Activity-Dependent
Notch Signaling in Direction of Neural
Transmission
To understand whether Jagged1 loss interferes with basal
expression of Notch1, we performed chromagen immunolabeling
on cage control TAM-injected Jag1cKO, TAM-injected
CamKIIcreERT2, and uninjected Jag1cKO and did not
observe any substantial difference (Figure S2B). Based on
our previous work showing that spatial exploration induces
Notch1 in CA field neurons (Alberi et al., 2011), we investigated
whether the loss of Jagged1 would interfere with the typical
exploration-induced increase in Notch1 in the CA fields. We
performed double immunolabeling for Notch1 and Jagged1
and quantified the fluorescence intensity of Notch in a random
selection of CA1 neurons. We observed that Notch1 expression
was significantly lower in hippocampal ensembles of the CA1
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FIGURE 2 | Targeted loss of Jagged1 in adult mouse neurons causes a spatial memory deficit. A schematic representation of the Jagged1 floxed allele used to
generate the mice with TAM-inducible loss of Jagged1 gene (A). Representative immunofluorescence images of single confocal z-plane showing a near complete loss
of Jagged1 protein (green) from hippocampal pyramidal neurons labeled by NeuN (red) of Jagged1cKO mice (B). Representative images from immunoblots showing
the expression of Jagged1, DNER in Jagged1cKO mice and control mice (C). GAPDH is used as a loading control. Bar graph showing the quantitation of optical
densities of Jagged1 and DNER bands in CTLs and Jagged1cKO mice (D). A graphic showing the behavioral arena for Y-maze spontaneous alternation test (E).
Jagged1cKO mice show a significant deficit in hippocampus dependent working memory in the Y-maze spontaneous alternation test (F). A diagram showing the
experimental arena for the hidden arm version of the Y-maze (G). Jagged1cKO mice show a significant reduction in the time spent in the hidden arm, suggesting a
spatial memory defect (H). A schematic showing the experimental setup for the Novel Object Displacement test (I). Jagged1cKO mice exhibit a statistical significant
reduction in discrimination index, a measure of spatial memory defect (J). Scale bar in (B) is 50 µm. Graphs are represented as mean ± SEM, *p<0.05, **p<0.01,
and ***p < 0.001.
field in Jagged1cKO mice as compared to CTL mice [CTLs,
median: 53.57, IQR: 48.38, UCTL: 1,288 ; Jagged1cKO, median:
25.58, IQR: 35.13, UKO: 3,611, p < 0.001, n = 6 animals
per group; Figure 3A]. The distribution of Notch1 intensities
shows that in CTL mice the majority (74%) of counted neurons
express high levels of Notch1 (50–120 AU) as opposed to
Jagged1cKO (36%; Figure 3B). In order to ascertain whether
Notch signaling activation is affected by the loss of Jagged1,
we examined the expression of the transcriptional Notch
target, Hes5 (Kopan and Ilagan, 2009), in CA1 fields following
spatial exploration. Similar to Notch1, in the Jagged1cKO, Hes5
expression was significantly weaker as compared to CTL mice
(CTLs, median: 28.52, IQR: 54.21, UCTL: 1,423; Jagged1cKO,
median: 15.13, IQR: 18.46, UKO: 3,057, p < 0.001, n = 6 animals
per group; Figure 3C). The distribution of Hes5 intensities
shows that in Jagged1cKO mice all counted neurons (100%)
express low levels of Hes5 (0–50 AU) as opposed to a CTL
mice spanning the whole range of intensities (0–110 AU;
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FIGURE 3 | Jagged1 regulates learning-dependent Notch induction and is enriched presynaptically. Fluorescent double-labeling shows the expression of Notch1 (red)
following spatial exploration in CTLs and Jagged1cKO (A). Jagged1 labeling (green) is used to validate the absence of Jagged1 in the Jagged1cKO (Jag1cKOs) (A,C).
Diagram summarizing the Notch1 fluorescence intensities distribution in randomly picked 69 and 71 CA1 neurons in CTLs and Jagged1cKOs, respectively (p <
0.001) (B). Double immunofluorescence of the Notch1 transcriptional target, Hes5, in CTLs and JaggedcKOs following spatial exploration (C). Diagram summarizing
the Hes5 fluorescence intensity distribution in randomly picked 64 and 70 CA1 neurons in CTL and Jagged1cKO, respectively (p < 0.001) (D). Representatives gold
Immuno-electron microscopy panels from three WT mice show that Jagged1 particles are localized in presynaptic terminals, bound to presynaptic vesicles (Pre)
(E–E′′′). Immunogold particles are also apparent at the Postsynaptic density (Post) (E,E′′,E′′′). Box Plot summarizing the particle counts in presynaptic and
postsynaptic terminal areas drawn on Immunoelectromicroscopy micrograph for Jagged1 indicates that the presynapse is enriched with Jag1 particles as compared
to the postsynaptic terminal (p < 0.001) (F). Scale bars are: 20 µm in (A), 10 µm in (C), 400 nm in (E–E′′′). AU, arbitrary units; Pre, presynaptic; Post, postsynaptic;
and Ax, axon.
Figure 3D). The results indicate that the loss of Jagged1 affects
the induction of Notch1 expression and activity in ensembles of
neurons.
To further assess whether Jagged1 modulates synaptic activity
in direction of transmission in neurons, we used immuno-
gold electron microscopy to visualize and quantify Jagged1
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positive particles in the CA3-CA1 synapses. The Jagged1
immunoparticles appear localized to presynaptic vesicles and
also concentrated at the synaptic junction (Figures 3E–E′′′). The
counting of gold particles on hippocampal synapses reveals that
the presynaptic terminals are enriched in Jagged1 as compared
to the postsynaptic side [presynaptic: 1.01 ∗ 10−3 ± 4.36 ∗
10−4/ nm2, postsynaptic: 2.86 ∗ 10−4 ± 1.36 ∗ 10−4/ nm2;
F(1, 30) = 10.11, p = 0.003, n = 21 presynaptic and n
= 21 postsynaptic areas, n = 3 wildtype mice; Figure 3F].
The presynaptic localization of Jagged1 and the postsynaptic
enrichment of Notch1 (Brai et al., 2015) in hippocampal neurons
suggests that the ligand and receptor are positioned in the
direction of synaptic transmission and emphasize that Jagged1
may function as a presynaptic modulator of activity-dependent
Notch signaling upon spatial learning.
DISCUSSION
The cell signaling pathways that influence neuronal activity and
plasticity have received an increased attention in recent years.
Further casting light on such signaling mechanism would allow
us to devise better strategies against cognitive loss in progressive
neurological diseases, such as AD. We have previously shown
that a ubiquitous signaling pathway, such as Notch1, which is
involved in cellular communication from development onward,
is also essential for the formation of spatial memory (Alberi
et al., 2011). In addition, Notch ligand Jagged1 influences
synaptic potentiation (Wang et al., 2004) as well as memory
formation (Sargin et al., 2013). This involvement of Notch
signaling pathway in the process of memory formation seems
to be conserved across species and may act via increasing
phosphorylation of plasticity associated protein, CREB (Zhang
et al., 2013; Brai et al., 2015). These results suggest that Notch
pathway is an integral part of signaling networks involved in
memory formation. Hence, it is tempting to speculate that the
Notch signaling pathway may be compromised in patients with
neurological disorders characterized by dementia, such as AD.
Indeed, Notch signaling dysfunction has been implicated in
sporadic as well as familial AD patients (Berezovska et al., 1998;
Moehlmann et al., 2002; Brai et al., 2016). This decrease in Notch
activity could stem from the misexpression of one or multiple
Notch ligands. However, identity of such ligands had not been
ascertained. The Notch ligand, Jagged1 has been shown to be
expressed predominantly in neurons in the adult central nervous
system (Stump et al., 2002; Alberi et al., 2011), and its constitutive
downregulation results in severe memory deficits (Sargin et
al., 2013). Interestingly, patients with Alagille syndrome, an
autosomal dominant disorder caused by mutations in Jagged1 (Li
et al., 1997; Ropke et al., 2003), show signs of mental retardation,
besides systemic abnormalities. This further supports the
involvement of Jagged1 in neuronal function through the
Notch signaling cascade. Hence, in this paper, we investigated
whether Jagged1 functions upstream of Notch signaling to
regulate spatial memory, and its misexpression is involved
in AD pathophysiology. Previous work from our laboratory
indicated that Jagged1 and Notch1 are expressed in neurons in
a stereotypical pattern with Jagged1 at presynaptic puncta and
Notch1 at the postsynaptic terminal using primary neuronal
cultures (Alberi et al., 2011). The immuno-electronmicroscopy
for Jagged1 on fixed mouse hippocampal sections, presented
in this paper, confirms that Jagged1 is predominantly located
presynaptically and is associated to presynaptic vesicles. The
presynaptic positioning of Jagged1 warrants ligand to receptor
signaling in the direction of neural transmission, suggesting
that an alteration in ligand availability may interfere with
synaptic information exchange as in dementia (Huang et al.,
2012). Indeed, we observe that in patients with severe dementia,
Jagged1 expression is critically reduced (Figure 1), supporting
the reduction in Notch activity in AD brains (Brai et al.,
2016). Jagged1 labeling can also be found in fibrillary aggregates
together with Notch1 likely as a result of neurites’ break down.
Moreover, the decrease of Jagged1 protein in the brain, as
detected in the CSF of MCI and AD patients, appears to be
gradual with the increasing severity of dementia (Figure 1). The
specific implication of Jagged1 in Notch-dependent functions
is emphasized by the evidence that the other Notch ligand,
DNER, which is also expressed in hippocampal neurons (Kurisu
et al., 2010), remains virtually unchanged with the progression
of dementia (Figure 1). The alteration of Notch signaling
components in AD underlines the potential involvement of this
pathway in affecting synaptic transmission and emphasizes its
role in memory decline.
Since the postnatal loss of Notch1 in the CA hippocampal
fields (Alberi et al., 2011) and partial loss of Notch1, RBPJK and
Jagged1 in heterozygous mice (Sargin et al., 2013) results in a
learning and memory deficit, we next addressed whether Jagged1
misexpression is sufficient to induce memory decline. In order
to knockout Jagged1 gene during adulthood, we have devised
a conditional KO mouse for Jagged1, using TAM inducible
Cre (Jagged1cKO) (Figure 2). The advantage of this model as
compared to the one used by Sargin (Sargin et al., 2013) is that
gene deletion is induced only in the adult brain and it is nearly
complete (80%), eliminating any confounding developmental
effects of residual Jagged1 function. This also indicates that
the majority of Jagged1 is expressed in neurons as opposed
to other cell types in the brain. Similarly to the Notch1cKOs,
Jagged1cKO display a spatial reference memory deficit in the
Y-maze and NOD tests (Figure 2). Using a different battery of
tests for spatial memory, Sargin and colleagues also found a
deficit in spatial memory formation in the Jagged1+/− mice. This
emphasizes that Jagged1, comparably to Notch1, is required for
spatial memory in adult mice and that dosage of the ligand may
be critical for activity-dependent Notch signaling. To further
resolve the functional correlation between Jagged1 and Notch1
activity in spatial learning and memory, we showed that the
loss of Jagged1 affects the learning-dependent induction of
Notch1 expression and its activity, as indicated by the absence
of CA1 neurons expressing detectable levels of Hes5 (Figure 3).
The loss of Jagged1 not only interferes with Notch pathway
activation but may affect the known positive feedback regulation
of DSL ligands on the signal sending neuron, depleting further
the synapse of putative Notch ligands (D’Souza et al., 2008).
Thus, Jagged1 appears to regulate Notch-dependent plasticity
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in an activity-dependent manner. This is in line with previous
data showing that Jagged1 expression and Notch1 signaling are
induced by an increase in synaptic activity (Alberi et al., 2011)
and is further supported by evidence that a soluble peptide of
Jagged1 can potentiate LTP (Wang et al., 2004) and activate
Notch1 in neuronal cultures (data not shown). The evidence
that in the setting of neurons a soluble form of Jagged1 can
induce Notch1 pathway activation is in stark contrast to the
reported requirement in stem cells of a membrane bound ligand
to exercise a pulling force on the extracellular portion of the
Notch to activate the receptor (Hansson et al., 2010). However,
a previous report showed that the shedding of Jagged1 from
the cell signaling cell is induced by the interaction with Notch
and is mediated by ADAM-17 (LaVoie and Selkoe, 2003).
Likewise in neurons, Jagged1 may exist both in a membrane-
bound and soluble form. Indeed, from our IEM data, it appears
that Jagged1 is present in presynaptic vesicles (Figure 3), and
may be deployed upon synaptic stimulation, similar to a
neurotransmitter. In condition of elevated synaptic activity, it
is conceivable that the soluble ligand activates Notch in the
postsynaptic compartment, where the receptor is enriched (Brai
et al., 2015), and Notch1 processing results from the clustering
of the endosomal trafficking molecule Arc/Arg3.1 to the γ -
secretase complex (Alberi et al., 2011; Wu et al., 2011). To this
effect, we show that either the loss of Jagged1 or Arc/Arg3.1 can
affect learning-dependent Notch activation and result in a spatial
memory deficit. In light of these results, the observed reduction
of Jagged1 in AD may cause a reduction in Notch1 activity,
underlying the memory decline.
Altogether, this work expands our understanding of the role
of Notch signaling in learning and memory and emphasizes
the relevance of presynaptic Jagged1 ligand in neurons in
potentiating neuronal Notch activity. This work suggests that
modulation of the pathway, through Jagged1 application, could
be a therapeutically viable approach to counteract cognitive
decline in dementia.
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Figure S1 | Severe brain atrophy of AD specimen and pattern of Jagged1 and
DNER expression in CSF of MCI and Healthy control patients. Representative
DAPI staining of enthorinal sections from healthy CTL and AD patient show the
substantial atrophy of the hippocampal (HP) and cortical (EC) regions as well as
the enlargement of the ventricle (V) in a AD patient as compared to a Healthy
control (A). Immunoblotting on CSF from 5 MCI and 5 Healthy control patients
reveals that Jagged1 bands >130 KDa (blue stars) corresponding to the full length
and the and <130 KDa (red stars) indicating the soluble Jagged1 tend to be less
represented in the CSF from AD patients (B). Representative DNER
immunoblotting of the CSF from the same patients shows no differennce in the
expected band <100 KDa (blue stars) (C). Scale bar is 5mm.
Figure S2 | Jagged1 and Notch1 basal expression in TAM-injected
and -uninjected transgenic mice. Representative Jagged1 chromagen
immunohistochemistry on saggital sections shows the loss of Jagged1 expression
in the hippocampal CA fields of the TAM-injected Jag1cKO as compared to
TAM-injected CamKIIcre ERT2 mice and uninjected Jag1cKO (A). Chromagen
immunolabeling showing the expression of Notch1 in the three mouse lines used
in the study (B). Scale bars in (A,B) is 5 mm.
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